Levels of the cancer biomarker CA 19-9 are associated with thrombin generation in plasma from treatment-na ïve pancreatic cancer patients

Pancreatic ductal adenocarcinoma (PDAC) is associated with a hypercoagulable state and high mortality. Increases in the plasma levels of tumor marker carbohydrate antigen (CA) 19-9 are used in diagnosis and follow-up but have also been reported to precede venous thromboembolism (VTE).

Source: Thrombosis Research - December 21, 2020 Category: Hematology Authors: N. Mattila, Y. Hisada, B. Przybyla, J. Posma, A. Jouppila, C. Haglund, H. Sepp änen, N. Mackman, R. Lassila Source Type: research